# Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment

> **NCT01897727** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 41 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- Resistant Hypertension
- Hyperaldosteronism

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** BP medication uptitration

## Key facts

- **NCT ID:** NCT01897727
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-04
- **Final completion:** —
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01897727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01897727, "Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01897727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*